Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

NYSE:NYT - New York Stock Exchange, Inc. - US6501111073 - Common Stock - Currency: USD

48.03  -0.73 (-1.5%)

After market: 48.26 +0.23 (+0.48%)

Fundamental Rating

6

Overall NYT gets a fundamental rating of 6 out of 10. We evaluated NYT against 93 industry peers in the Media industry. Both the health and profitability get an excellent rating, making NYT a very profitable company, without any liquidiy or solvency issues. NYT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year NYT was profitable.
NYT had a positive operating cash flow in the past year.
NYT had positive earnings in each of the past 5 years.
Of the past 5 years NYT 4 years had a positive operating cash flow.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With an excellent Return On Assets value of 10.14%, NYT belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.12%, NYT belongs to the top of the industry, outperforming 83.91% of the companies in the same industry.
NYT has a better Return On Invested Capital (12.55%) than 91.95% of its industry peers.
Industry RankSector Rank
ROA 10.14%
ROE 15.12%
ROIC 12.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

With an excellent Profit Margin value of 11.04%, NYT belongs to the best of the industry, outperforming 85.06% of the companies in the same industry.
In the last couple of years the Profit Margin of NYT has grown nicely.
NYT's Operating Margin of 14.00% is fine compared to the rest of the industry. NYT outperforms 77.01% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 49.02%, NYT perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14%
PM (TTM) 11.04%
GM 49.02%
OM growth 3Y1.83%
OM growth 5Y6.74%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

NYT has an Altman-Z score of 7.83. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
NYT has a Altman-Z score of 7.83. This is amongst the best in the industry. NYT outperforms 95.40% of its industry peers.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.83
ROIC/WACC1.39
WACC9.06%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.35 indicates that NYT should not have too much problems paying its short term obligations.
NYT has a Current ratio of 1.35. This is comparable to the rest of the industry: NYT outperforms 44.83% of its industry peers.
NYT has a Quick Ratio of 1.35. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
NYT's Quick ratio of 1.35 is in line compared to the rest of the industry. NYT outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.56% over the past year.
Measured over the past years, NYT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.92% on average per year.
The Revenue for NYT has decreased by -13.42% in the past year. This is quite bad
NYT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.37% yearly.
EPS 1Y (TTM)22.56%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%14.29%
Revenue 1Y (TTM)-13.42%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%7.46%

3.2 Future

NYT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.70% yearly.
The Revenue is expected to grow by 5.52% on average over the next years.
EPS Next Y5.52%
EPS Next 2Y7.92%
EPS Next 3Y8.78%
EPS Next 5Y10.7%
Revenue Next Year6.51%
Revenue Next 2Y6.17%
Revenue Next 3Y5.51%
Revenue Next 5Y5.52%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.90, NYT is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of NYT is on the same level as its industry peers.
NYT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
NYT is valuated rather expensively with a Price/Forward Earnings ratio of 22.64.
Based on the Price/Forward Earnings ratio, NYT is valued a bit cheaper than the industry average as 62.07% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of NYT to the average of the S&P500 Index (22.68), we can say NYT is valued inline with the index average.
Industry RankSector Rank
PE 23.9
Fwd PE 22.64
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

NYT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NYT is more expensive than 63.22% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NYT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.39
EV/EBITDA 16.43
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NYT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.33
PEG (5Y)1.41
EPS Next 2Y7.92%
EPS Next 3Y8.78%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.48%, NYT has a reasonable but not impressive dividend return.
NYT's Dividend Yield is a higher than the industry average which is at 4.48.
NYT's Dividend Yield is slightly below the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

On average, the dividend of NYT grows each year by 21.18%, which is quite nice.
NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
NYT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)21.18%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

28.43% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.43%
EPS Next 2Y7.92%
EPS Next 3Y8.78%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (2/21/2025, 8:04:00 PM)

After market: 48.26 +0.23 (+0.48%)

48.03

-0.73 (-1.5%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners93.87%
Inst Owner Change3.87%
Ins Owners0.68%
Ins Owner Change0.01%
Market Cap7.87B
Analysts75
Price Target57.13 (18.95%)
Short Float %4.32%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.42
Dividend Growth(5Y)21.18%
DP28.43%
Div Incr Years6
Div Non Decr Years11
Ex-Date04-01 2025-04-01 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.26%
Min EPS beat(2)8.46%
Max EPS beat(2)10.06%
EPS beat(4)4
Avg EPS beat(4)23.07%
Min EPS beat(4)8.46%
Max EPS beat(4)55.15%
EPS beat(8)8
Avg EPS beat(8)30.32%
EPS beat(12)12
Avg EPS beat(12)29.68%
EPS beat(16)16
Avg EPS beat(16)31.53%
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)-0.64%
Revenue beat(8)3
Avg Revenue beat(8)-0.43%
Revenue beat(12)4
Avg Revenue beat(12)-0.49%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)-1.36%
PT rev (3m)0.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.96%
EPS NY rev (3m)1.29%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 23.9
Fwd PE 22.64
P/S 3.11
P/FCF 21.39
P/OCF 19.92
P/B 4.25
P/tB 6.73
EV/EBITDA 16.43
EPS(TTM)2.01
EY4.18%
EPS(NY)2.12
Fwd EY4.42%
FCF(TTM)2.25
FCFY4.67%
OCF(TTM)2.41
OCFY5.02%
SpS15.47
BVpS11.3
TBVpS7.14
PEG (NY)4.33
PEG (5Y)1.41
Profitability
Industry RankSector Rank
ROA 10.14%
ROE 15.12%
ROCE 16.34%
ROIC 12.55%
ROICexc 16.23%
ROICexgc 27.32%
OM 14%
PM (TTM) 11.04%
GM 49.02%
FCFM 14.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.83%
OM growth 5Y6.74%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score8
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 32.51%
Cap/Sales 1.07%
Interest Coverage 250
Cash Conversion 90.08%
Profit Quality 131.47%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 7.83
F-Score8
WACC9.06%
ROIC/WACC1.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.56%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%14.29%
EPS Next Y5.52%
EPS Next 2Y7.92%
EPS Next 3Y8.78%
EPS Next 5Y10.7%
Revenue 1Y (TTM)-13.42%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%7.46%
Revenue Next Year6.51%
Revenue Next 2Y6.17%
Revenue Next 3Y5.51%
Revenue Next 5Y5.52%
EBIT growth 1Y10.06%
EBIT growth 3Y9.58%
EBIT growth 5Y14.61%
EBIT Next Year30.67%
EBIT Next 3Y12.87%
EBIT Next 5YN/A
FCF growth 1Y39.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.43%
OCF growth 3YN/A
OCF growth 5YN/A